Tarje Onsøien Halvorsen

About

Specialist in medical and radiation oncology working with lung cancer patients. Teaching medical students in clinical oncology. Experienced clinical researcher. PhD in radiotherapy in small cell lung cancer based on a randomized clinical multicenter trial comparing once and twice daily radiotherapy in small cell lung cancer of limited stage (LS SCLC). As a postdoc the main focus has been a randomized controlled multicenter international trials comparing standard dose and high dose twice daily radiotherapy in LS SCLC and immunotherapy after chemoradiotherapy in LS SCLC. Involved in several translational projects investigating ctDNA, miRNA, AI, radiomics, genomic radiosensitivity and spatial transcriptomics. PI for several clinical trials, and NCI for a study on adjuvant immunotherapy in stage III NSCLC treated with curative radiochemotherapy. Main supervisor for three completed PhDs and several medical students.

Education:

Cand. med.(MD), Universitety of Oslo, 2003
PhD in palliativ medicine, NTNU, 2017
Specialist in medical and radiation oncology, St. Olavs Hospital, 2019

Positions:

Consultant in oncology Kreftklinikken, St. Olavs hospital
Accociate professor, IKOM, NTNU
Postdoctoral research fellow, IKOM, NTNU

Research interests:

Radiotherapy in small cell lung cancer
Prognostic and predictive biomarkers
Artificial intelligence (AI)
Radiomics

Research

Publications

2024

Levin, Nina; Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien. (2024) Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics
Academic article
Graabak, Gustav; Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien. (2024) Effect of FDG PET-CT for Staging and Radiotherapy Planning – A Comparison of Cohorts From Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC. JTO Clinical and Research Reports
Academic article

2023

Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Kirkevold, Øyvind; Halvorsen, Tarje Onsøien. (2023) Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC. Journal of Thoracic Oncology
Academic article
Ottestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Dai, Hong Yan; Wahl, Sissel Gyrid Freim; Emdal, Elisabeth Fritzke. (2023) Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer. BMC Cancer
Academic article
Ottestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Dai, Hong Yan; Wahl, Sissel Gyrid Freim; Emdal, Elisabeth Fritzke. (2023) Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by <sup>18</sup>F-FDG PET/CT in early-stage non-small cell lung cancer (BMC Cancer, (2023), 23, 1, (646), 10.1186/s12885-023-11147-z). BMC Cancer
Errata
Taranova, Evgenia; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Slaaen, Marit; Aanerud, Marianne. (2023) Associations between patient-reported nutritional status, survival, and toxicity among patients with limited stage small-cell lung cancer (LS SCLC) in a randomized trial of high-dose, twice-daily (BID) thoracic radiotherapy (TRT). Journal of Clinical Oncology
Abstract
Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Bjaanæs, Maria Moksnes; Madebo, Tesfaye; Schytte, Tine. (2023) Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC). Journal of Clinical Oncology
Abstract
Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2023) Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC). American Journal of Clinical Oncology
Abstract

2022

Ottestad, Anine Larsen; Emdal, Elisabeth Fritzke; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Dai, Hong Yan. (2022) Fragmentation assessment of FFPE DNA helps in evaluating NGS library complexity and interpretation of NGS results. Experimental and molecular pathology (Print)
Academic article
Stokke, Kristin; Sandvei, Marie Søfteland; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2022) Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer. Clinical Medicine Insights: Oncology
Academic article
Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Langer, Seppo W.; Nyman, Jan. (2022) Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer. Lung Cancer
Academic article
Stokke, Kristin; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning; Saltvedt, Ingvild; Jordhøy, Marit Slaaen; Kirkevold, Øyvind. (2022) Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC. Healthcare
Academic article
Graabak, Gustav; Grønberg, Bjørn Henning; Sandvei, Marie Søfteland; Nilssen, Yngvar; Halvorsen, Tarje Onsøien. (2022) Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018. JTO Clinical and Research Reports
Academic article
Horndalsveen, Henrik; Alver, Tine Norman; Dalsgaard, Astrid Marie; ROGG, LOTTE VICTORIA; Helbekkmo, Nina; Grønberg, Bjørn Henning. (2022) Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT-1 trial. Molecular Oncology
Academic article
Levin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2022) Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer. Radiotherapy and Oncology
Abstract

2021

Wahl, Sissel Gyrid Freim; Hong, Yan Dai; Emdal, Elisabeth Fritzke; Berg, Thomas; Halvorsen, Tarje Onsøien; Ottestad, Anine Larsen. (2021) The prognostic effect of KRAS mutations in non-small cell lung carcinoma revisited: A norwegian multicentre study. Cancers
Academic article
Wahl, Sissel Gyrid Freim; Hong, Yan Dai; Emdal, Elisabeth Fritzke; Ottestad, Anine Larsen; Dale, Vibeke Grotnes; Richardsen, Elin. (2021) Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy. The journal of pathology. Clinical research
Academic article
Grønberg, Bjørn Henning; Langer, Seppo W.; Nyman, Jan; Halvorsen, Tarje Onsøien. (2021) Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer – Authors' reply. The Lancet Oncology
Letter to the editor
Ottestad, Anine Larsen; Hong, Yan Dai; Halvorsen, Tarje Onsøien; Emdal, Elisabeth Fritzke; Wahl, Sissel Gyrid Freim; Grønberg, Bjørn Henning. (2021) Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer. Cancer Treatment and Research Communications
Academic article
Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Brustugun, Odd; HORNSLIEN, KJERSTI; Madebo, Tesfaye. (2021) High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. The Lancet Oncology
Academic article

2020

Sjøgren, Kristina; Jacobsen, Kristian Aalberg; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien. (2020) Timing of severe toxicity from chemotherapy in patients with lung cancer. Anticancer Research
Academic article
Halvorsen, Tarje Onsøien; Valan, Christine Damgaard; Jordhøy, Marit Slaaen; Grønberg, Bjørn Henning. (2020) Associations between muscle measures, survival and toxicity in patients with limited disease small cell lung cancer. Journal of Cachexia, Sarcopenia and Muscle
Academic article
Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Jordhøy, Marit Slaaen; Grønberg, Bjørn Henning. (2020) Changes in muscle measures during chemoradiotherapy in patients with limited stage small cell lung cancer. JCSM Clinical Reports
Academic article
Halvorsen, Tarje Onsøien; Stokke, Kristin; Killingberg, Kristin Toftaker; Raj, Sunil Xavier; Sørhaug, Sveinung; Brustugun, Odd Terje. (2020) Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Acta Oncologica
Academic article

2019

Grønberg, Bjørn Henning; Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Sjøblom, Bjørg; Jordhøy, Marit Slaaen. (2019) Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients. Journal of Cachexia, Sarcopenia and Muscle
Academic article

2018

Valan, Christine Damgaard; Slagsvold, Jens Erik; Halvorsen, Tarje Onsøien; Herje, Martin; Bremnes, Roy M.; Brunsvig, Paal Fr.. (2018) Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement. Anticancer Research
Academic article
Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning. (2018) Komorbiditet ved småcellet lungekreft og begrenset utbredelse (LD SCLC). Best Practice Onkologi/Hematologi
Article in business/trade/industry journal

2017

Krogstad, Hilde; Brunelli, Cinzia; Sand, Kari; Andersen, Eivind; Garresori, Herish; Halvorsen, Tarje Onsøien. (2017) Development of EirV3: A computer-based tool for patient-reported outcome measures in cancer. JCO Clinical Cancer Informatics
Academic article

Journal publications

Levin, Nina; Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien. (2024) Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics
Academic article
Graabak, Gustav; Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien. (2024) Effect of FDG PET-CT for Staging and Radiotherapy Planning – A Comparison of Cohorts From Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC. JTO Clinical and Research Reports
Academic article
Killingberg, Kristin Toftaker; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Kirkevold, Øyvind; Halvorsen, Tarje Onsøien. (2023) Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC. Journal of Thoracic Oncology
Academic article
Ottestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Dai, Hong Yan; Wahl, Sissel Gyrid Freim; Emdal, Elisabeth Fritzke. (2023) Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer. BMC Cancer
Academic article
Ottestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Dai, Hong Yan; Wahl, Sissel Gyrid Freim; Emdal, Elisabeth Fritzke. (2023) Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by <sup>18</sup>F-FDG PET/CT in early-stage non-small cell lung cancer (BMC Cancer, (2023), 23, 1, (646), 10.1186/s12885-023-11147-z). BMC Cancer
Errata
Taranova, Evgenia; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Slaaen, Marit; Aanerud, Marianne. (2023) Associations between patient-reported nutritional status, survival, and toxicity among patients with limited stage small-cell lung cancer (LS SCLC) in a randomized trial of high-dose, twice-daily (BID) thoracic radiotherapy (TRT). Journal of Clinical Oncology
Abstract
Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Bjaanæs, Maria Moksnes; Madebo, Tesfaye; Schytte, Tine. (2023) Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC). Journal of Clinical Oncology
Abstract
Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2023) Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC). American Journal of Clinical Oncology
Abstract
Ottestad, Anine Larsen; Emdal, Elisabeth Fritzke; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Dai, Hong Yan. (2022) Fragmentation assessment of FFPE DNA helps in evaluating NGS library complexity and interpretation of NGS results. Experimental and molecular pathology (Print)
Academic article
Stokke, Kristin; Sandvei, Marie Søfteland; Grønberg, Bjørn Henning; Jordhøy, Marit Slaaen; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2022) Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer. Clinical Medicine Insights: Oncology
Academic article
Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Langer, Seppo W.; Nyman, Jan. (2022) Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer. Lung Cancer
Academic article
Stokke, Kristin; Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning; Saltvedt, Ingvild; Jordhøy, Marit Slaaen; Kirkevold, Øyvind. (2022) Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC. Healthcare
Academic article
Graabak, Gustav; Grønberg, Bjørn Henning; Sandvei, Marie Søfteland; Nilssen, Yngvar; Halvorsen, Tarje Onsøien. (2022) Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018. JTO Clinical and Research Reports
Academic article
Horndalsveen, Henrik; Alver, Tine Norman; Dalsgaard, Astrid Marie; ROGG, LOTTE VICTORIA; Helbekkmo, Nina; Grønberg, Bjørn Henning. (2022) Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT-1 trial. Molecular Oncology
Academic article
Levin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2022) Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer. Radiotherapy and Oncology
Abstract
Wahl, Sissel Gyrid Freim; Hong, Yan Dai; Emdal, Elisabeth Fritzke; Berg, Thomas; Halvorsen, Tarje Onsøien; Ottestad, Anine Larsen. (2021) The prognostic effect of KRAS mutations in non-small cell lung carcinoma revisited: A norwegian multicentre study. Cancers
Academic article
Wahl, Sissel Gyrid Freim; Hong, Yan Dai; Emdal, Elisabeth Fritzke; Ottestad, Anine Larsen; Dale, Vibeke Grotnes; Richardsen, Elin. (2021) Prognostic value of absolute quantification of mutated KRAS in circulating tumour DNA in lung adenocarcinoma patients prior to therapy. The journal of pathology. Clinical research
Academic article
Grønberg, Bjørn Henning; Langer, Seppo W.; Nyman, Jan; Halvorsen, Tarje Onsøien. (2021) Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer – Authors' reply. The Lancet Oncology
Letter to the editor
Ottestad, Anine Larsen; Hong, Yan Dai; Halvorsen, Tarje Onsøien; Emdal, Elisabeth Fritzke; Wahl, Sissel Gyrid Freim; Grønberg, Bjørn Henning. (2021) Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer. Cancer Treatment and Research Communications
Academic article
Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Fløtten, Øystein; Brustugun, Odd; HORNSLIEN, KJERSTI; Madebo, Tesfaye. (2021) High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial. The Lancet Oncology
Academic article
Sjøgren, Kristina; Jacobsen, Kristian Aalberg; Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien. (2020) Timing of severe toxicity from chemotherapy in patients with lung cancer. Anticancer Research
Academic article
Halvorsen, Tarje Onsøien; Valan, Christine Damgaard; Jordhøy, Marit Slaaen; Grønberg, Bjørn Henning. (2020) Associations between muscle measures, survival and toxicity in patients with limited disease small cell lung cancer. Journal of Cachexia, Sarcopenia and Muscle
Academic article
Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Jordhøy, Marit Slaaen; Grønberg, Bjørn Henning. (2020) Changes in muscle measures during chemoradiotherapy in patients with limited stage small cell lung cancer. JCSM Clinical Reports
Academic article
Halvorsen, Tarje Onsøien; Stokke, Kristin; Killingberg, Kristin Toftaker; Raj, Sunil Xavier; Sørhaug, Sveinung; Brustugun, Odd Terje. (2020) Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Acta Oncologica
Academic article
Grønberg, Bjørn Henning; Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Sjøblom, Bjørg; Jordhøy, Marit Slaaen. (2019) Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients. Journal of Cachexia, Sarcopenia and Muscle
Academic article
Valan, Christine Damgaard; Slagsvold, Jens Erik; Halvorsen, Tarje Onsøien; Herje, Martin; Bremnes, Roy M.; Brunsvig, Paal Fr.. (2018) Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement. Anticancer Research
Academic article
Halvorsen, Tarje Onsøien; Grønberg, Bjørn Henning. (2018) Komorbiditet ved småcellet lungekreft og begrenset utbredelse (LD SCLC). Best Practice Onkologi/Hematologi
Article in business/trade/industry journal
Krogstad, Hilde; Brunelli, Cinzia; Sand, Kari; Andersen, Eivind; Garresori, Herish; Halvorsen, Tarje Onsøien. (2017) Development of EirV3: A computer-based tool for patient-reported outcome measures in cancer. JCO Clinical Cancer Informatics
Academic article

Knowledge Transfer

2023

Poster

Ottestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Dai, Hong Yan; Wahl, Sissel Gyrid Freim; Emdal, Elisabeth Fritzke. (2023) High tumor metabolic activity is associated with circulating tumor DNA detection in early-stage lung cancer patients. 13th International Symposium on Minimal Residual Cancer 2023-05-02 - 2023-05-04
Lecture

Levin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2023) Dose-response of acute esophagitis for limited stage small cell lung cancer - Data from a randomized phase II trial. Acta Oncologica BiGART , Aarhus, Danmark 2023-06-20 - 2023-06-21
Lecture

Grønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2023) Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC). ASCO ASCO 2023 , Chicago 2023-06-02 - 2023-06-06

2022

Academic lecture

Ottestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Sandvei, Marie Søfteland; Grønberg, Bjørn Henning. (2022) Association between ctDNA detection and tumor metabolic activity measured by PET/CT . Clinical implementation of liquid biopsy in the treatment of lung cancer 2022-11-10 - 2022-11-10
Lecture

Levin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2022) Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer. European Society for Radiotherapy and Oncology (ESTRO) ESTRO 2022 , København 2022-05-06 - 2022-05-10

2019

Poster

Stokke, Kristin; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Sørhaug, Sveinung; Madebo, Tesfaye; Raj, Sunil Xavier. (2019) Randomized phase III trial comparing maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Verdenskonferansen for lungekreft, WCLC , Barcelona 2019-09-07 - 2019-09-10
Poster

Wahl, Sissel Gyrid Freim; Dai, Hong Yan; Emdal, Elisabeth Fritzke; Ottestad, Anine Larsen; Richardsen, Elin; Halvorsen, Tarje Onsøien. (2019) Prognostic value of mutated KRAS in circulating tumor DNA prior to therapy in patients with lung cancer. IASLC World Conference on Lung Cancer 2019 , Barcelona 2019-09-07 - 2019-09-10

2016

Lecture

Halvorsen, Tarje Onsøien. (2016) Thorakal strålebehandling ved småcellet lungekreft begrenset utbredelse. Norsk Onkologisk Forening Onkologisk Forum 2016 , Trondheim 2016-11-16 - 2016-11-17

2015

Poster

Grønberg, Bjørn Henning; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf. (2015) Association between comorbidity, treatment toxicity and overall survival in limited disease small-cell lung cancer. International Association for the study of Lung Cancer 16TH WORLD CONFERENCE ON LUNG CANCER , Denver, Colorado 2015-09-06 - 2015-09-09
Poster

Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Levin, Nina; Bremnes, Roy M.; Brunsvig, Paal Fr.; Brustugun, Odd Terje. (2015) Survival of patients with N3 lymph node disease in a cohort with limited disease small-cell lung cancer receiving concurrent chemoradiotherapy. International Association for the study of Lung Cancer 16TH WORLD CONFERENCE ON LUNG CANCER , Denver, Colorado 2015-09-06 - 2015-09-09
Academic lecture

Halvorsen, Tarje Onsøien. (2015) Småcellet lungekreft med begrenset utbredelse. Skal pasienter med komorbiditet motta standard behandling ?. Forskningsavdelingen i Helse Nord-Trøndelag Regional forskningskonferanse 2015 , Stjørdal 2015-06-09 - 2015-06-10
Academic lecture

Halvorsen, Tarje Onsøien. (2015) EIR – et klinisk verktøy for symptomkartlegging og beslutningsstøtte . HEMIT Hemit-konferansen 2015 – IKT for liv og helse , Trondheim 2015-03-18 - 2015-03-18

2014

Academic lecture

Valan, Christine Damgaard; Halvorsen, Tarje Onsøien; Balstad, Trude Rakel; Sjøblom, Bjørg; Jordhøy, Marit; Solheim, Tora Skeidsvoll. (2014) The prognostic value of comorbidity and body muscle mass in patient with advanced non-small-cell lung cancer. European Association of Palliative Care 4th International Seminar of the PRC and EAPC RN , Amsterdam 2014-10-16 - 2014-10-17

2012

Poster

Grønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf. (2012) Phase II Trial Comparing Two Schedules of Thoracic Radiotherapy in Limited Disease Small-Cell Lung Cancer. American Society of Clinical Oncology ASCO Annual Meeting 2012 , Chicago 2012-06-01 - 2012-06-05

Språkvelger

Tarje Onsøien Halvorsen